Newsroom | 11856 results

Sorted by: Latest

Surgery
-

Dermatology Associates of San Antonio Joins Epiphany Dermatology

AUSTIN, Texas--(BUSINESS WIRE)--Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in Texas through its partnership with Dermatology Associates of San Antonio. Founded in 1985 by Dr. William Parsons, Dermatology Associates of San Antonio has a long-established reputation of providing high-quality dermatology services to patients in the greater San Antonio market. Dermatology Associates...
-

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us,” or “our”) today issued the following open letter to the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon Inc. (“Alcon”) (NYSE: ALC) on transaction terms that remain unchanged following the conclusion of the Company’s flawed and...
-

Byron Jobe Recognized as One of Modern Healthcare’s 100 Most Influential People in Healthcare

IRVING, Texas--(BUSINESS WIRE)--This recognition acknowledges individuals who are deemed to be the most influential figures in the industry in terms of leadership and impact....
-

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that leading proxy advisory firm Egan-Jones Ratings Company (“Egan-Jones”) has reaffirmed its recommendation that shareholders vote “AGAINST” the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC) on the GREEN Proxy Card. Earlier today, the Company announced the completion of the belated, band-aid 30-day go-s...
-

El SNQ del IBMI e ICHOM establecieron una alianza estratégica en Asia para promover la atención de salud centrada en el paciente en la región

TAIPÉI, Taiwán--(BUSINESS WIRE)--The Symbol of National Quality (SNQ), iniciativa del Instituto de Biotecnología e Industria Médica de Taiwán (Institute for Biotechnology and Medicine Industry [IBMI]), se asoció con el Consorcio Internacional para la Medición de Resultados en Salud (International Consortium for Health Outcomes Measurement [ICHOM]) con el objetivo de establecer un nuevo punto de referencia para los estándares de atención sanitaria en toda la región de Asia y el Pacífico. El acue...
-

Riassunto: IBMI SNQ e ICHOM formano una partnership strategica in Asia, promuovendo l'assistenza sanitaria incentrata sul paziente nella regione

TAIPEI, Taiwan--(BUSINESS WIRE)--Il Symbol of National Quality (SNQ), introdotto dall'Institute for Biotechnology and Medicine Industry (IBMI) di Taiwan, si è unito all'International Consortium for Health Outcomes Measurement (ICHOM) per segnare un nuovo punto di riferimento per gli standard sanitari nella regione Asia-Pacifico. L'accordo di collaborazione, firmato da Chen Wei-Jao, Chief Convener, Commissione SNQ, e Jennifer L. Bright, Presidente e CEO di ICHOM, ha segnato un sodalizio importan...
-

IBMI SNQとICHOMがアジアで戦略的パートナーシップを締結し、患者中心のヘルスケア推進に向けた取り組みを促進

台北、台湾--(BUSINESS WIRE)--(ビジネスワイヤ) -- 台湾のInstitute for Biotechnology and Medicine Industry(IBMI)が主導する「国家品質標章(SNQ)」は、International Consortium for Health Outcomes Measurement(ICHOM)と提携し、アジア太平洋地域における医療基準に新たなベンチマークを確立することを目指しています。 今回のパートナーシップ契約は、SNQ委員会のチーフ・コンビーナーである陳・維昭と、ICHOMの社長兼最高経営責任者(CEO)であるジェニファー・L・ブライト氏により署名され、IBMI SNQとICHOMの重要な協業を示すものとなりました。 IBMI SNQは、医療チームの世界水準の成果を評価するにあたり、構造・プロセス・アウトカムの3段階を重視した厳格な審査制度を導入しています。対象分野には、肝臓移植、膵がん手術、顎顔面再建、心房細動治療、重症治療、希少疾患に対する遺伝子治療などが含まれます。これらの成果により、台湾は世界的な医療品質の基準...
-

IBMI SNQ e ICHOM formam parceria estratégica na Ásia, promovendo cuidados de saúde centrados no paciente na região

TAIPEI, Taiwan--(BUSINESS WIRE)--O Símbolo de Qualidade Nacional (SNQ), iniciativa do Instituto de Biotecnologia e Indústria Médica de Taiwan (IBMI), firmou parceria com o Consórcio Internacional para Medição de Resultados em Saúde (ICHOM) para definir um novo padrão de referência para a área da saúde em toda a região da Ásia-Pacífico. O contrato de parceria, assinado por Chen Wei-Jao, Coordenador Principal do Comitê SNQ, e Jennifer L. Bright, Presidente e Diretora Executiva do ICHOM, represent...
-

Samenvatting: IBMI SNQ en ICHOM gaan strategisch partnerschap aan in Azië om patiëntgerichte gezondheidszorg in de regio te bevorderen

TAIPEI, Taiwan--(BUSINESS WIRE)--Het Symbol of National Quality (SNQ), een initiatief van het Taiwanese Institute for Biotechnology and Medicine Industry (IBMI), is een samenwerking aangegaan met het International Consortium for Health Outcomes Measurement (ICHOM) om een nieuwe norm voor gezondheidszorg in de regio Azië-Pacific vast te stellen. De samenwerkingsovereenkomst, ondertekend door Chen Wei-Jao, hoofdcoördinator van het SNQ-comité, en Jennifer L. Bright, president en CEO van ICHOM, mar...
-

IBMI SNQ und ICHOM gehen zur Förderung einer patientenorientierten Gesundheitsversorgung in der Region eine strategische Partnerschaft in Asien ein

TAIPEH, Taiwan--(BUSINESS WIRE)--Das Symbol of National Quality (SNQ), initiiert vom taiwanesischen Institut for Biotechnology and Medicine Industry (IBMI), ist eine Partnerschaft mit dem International Consortium for Health Outcomes Measurement (ICHOM) eingegangen, um einen neuen Maßstab für Standards im Gesundheitswesen im asiatisch-pazifischen Raum zu setzen. Die Partnerschaftsvereinbarung, unterzeichnet von Chen Wei-Jao, Chief Convener, SNQ Committee, und Jennifer L. Bright, President und CE...